Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets (Details)

v3.20.1
Intangible Assets (Details) - USD ($)
3 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Intangible Assets    
Clinical trial data $ 250,000 $ 250,000
Accumulated Amortization and impairment (229,167) (104,167)
Total Intangible Assets $ 20,833 $ 145,833
Estimated Useful Life 6 years